Risk and Outcomes of Reintervention After Transcatheter Aortic Valve Implantation
Listen to this summary
This study investigates the time-varying risk and outcomes of reintervention after transcatheter aortic valve implantation (TAVI) in Medicare patients. The authors found that the hazard of reintervention increased significantly over time, particularly after 7 years, with valve stenosis being the most common reason for reintervention. While mortality rates remained consistent across different time intervals, the risk of heart failure hospitalizations was notably higher following early reinterventions, suggesting a need for tailored post-TAVI care.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The Annals of thoracic surgery
View all →Jun 9, 2026 · The Annals of thoracic surgery
Graft-Assisted Transapical Transcatheter Aortic Valve Replacement with Concomitant Robotic Minimally Invasive Direct Coronary Artery Bypass
Jun 9, 2026 · The Annals of thoracic surgery
Preoperative Resting Heart Rate and 30-Day Heart Failure After Off-Pump Coronary Artery Bypass Grafting
Jun 9, 2026 · The Annals of thoracic surgery
STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPY
More in Thoracic Surgery (Cardiothoracic Vascular Surgery)
View all →Aug 6, 2026 · Circulation
Surviving Pediatric Cardiogenic Shock: Clinical Approach, Improving Outcomes, and Future Directions: A Scientific Statement From the American Heart Association
Aug 6, 2026 · JAMA
Iron or Multiple Micronutrient Powder Supplements With Malaria Chemoprevention in Rural Malawian Children: The IRMA Randomized Clinical Trial
Aug 6, 2026 · Lancet (London, England)
[<sup>177</sup>Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
Aug 5, 2026 · JAMA
Duration of Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: The ICECAP Randomized Clinical Trial
Aug 5, 2026 · The New England journal of medicine
Syncope
Aug 4, 2026 · Circulation
Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


